PAGLIARULO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 5.119
EU - Europa 2.016
AS - Asia 2.010
SA - Sud America 537
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 66
OC - Oceania 4
Totale 9.875
Nazione #
US - Stati Uniti d'America 5.036
SG - Singapore 848
IT - Italia 782
CN - Cina 428
BR - Brasile 413
HK - Hong Kong 265
SE - Svezia 251
DE - Germania 220
RU - Federazione Russa 176
VN - Vietnam 134
UA - Ucraina 131
FR - Francia 126
FI - Finlandia 101
GB - Regno Unito 89
IN - India 71
BD - Bangladesh 40
CA - Canada 37
AR - Argentina 33
ID - Indonesia 27
IL - Israele 26
BE - Belgio 22
MX - Messico 21
VE - Venezuela 20
ES - Italia 19
IQ - Iraq 19
PL - Polonia 19
ZA - Sudafrica 19
EC - Ecuador 18
JP - Giappone 18
IE - Irlanda 17
CO - Colombia 16
PK - Pakistan 16
SA - Arabia Saudita 16
TR - Turchia 16
CL - Cile 14
CI - Costa d'Avorio 13
MA - Marocco 11
MY - Malesia 11
PH - Filippine 11
PY - Paraguay 11
LT - Lituania 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
NL - Olanda 9
AE - Emirati Arabi Uniti 8
NP - Nepal 7
TN - Tunisia 7
AT - Austria 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
BO - Bolivia 5
NI - Nicaragua 5
PT - Portogallo 5
AU - Australia 4
KG - Kirghizistan 4
LB - Libano 4
PS - Palestinian Territory 4
AL - Albania 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
MK - Macedonia 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
OM - Oman 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
MR - Mauritania 1
NO - Norvegia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 9.749
Città #
Fairfield 461
Ashburn 457
Singapore 425
Woodbridge 397
Chandler 331
San Jose 327
Jacksonville 303
Houston 295
Hong Kong 265
Milan 207
Seattle 201
Nyköping 187
Ann Arbor 177
Cambridge 161
Wilmington 161
Council Bluffs 129
Beijing 117
Roxbury 75
Lauterbourg 74
Rome 74
Lawrence 73
Dallas 69
Nanjing 67
Inglewood 59
Los Angeles 59
Boardman 48
New York 46
Santa Clara 45
Des Moines 44
São Paulo 44
Ho Chi Minh City 42
Columbus 36
Brooklyn 29
Buffalo 29
Hanoi 28
Helsinki 27
Bari 25
Princeton 25
Brussels 21
Tel Aviv 21
Atlanta 19
Bologna 18
Hebei 18
Warsaw 18
Dublin 17
Munich 17
Nanchang 17
Tokyo 17
Changsha 16
Falkenstein 16
Frankfurt am Main 16
Jiaxing 16
Moscow 16
Figino 15
Naples 14
Abidjan 13
London 13
Phoenix 13
Shenyang 13
Johannesburg 12
Chicago 11
Dearborn 11
Denver 11
San Francisco 11
Belo Horizonte 10
Boston 10
Da Nang 10
Paris 10
Tianjin 10
Toronto 10
Baghdad 9
Brasília 9
Florence 9
Orem 9
Poplar 9
Tashkent 9
Brno 8
Osasco 8
The Dalles 8
Caracas 7
Chennai 7
Lahore 7
Manchester 7
Mexico City 7
Quito 7
Rio de Janeiro 7
San Diego 7
Shanghai 7
Curitiba 6
Delhi 6
Guangzhou 6
Haiphong 6
Miami 6
Montreal 6
New Delhi 6
Norwalk 6
Ottawa 6
Riyadh 6
Stockholm 6
São Bernardo do Campo 6
Totale 6.292
Nome #
Linfadenectomia iliaco-otturatoria: quando e perchè 374
Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins 225
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 182
The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line 166
Antiproliferative activity evaluation of a series of N-1,3-benzothiazol-2-ylbenzamides as novel apoptosis inducers 162
Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer 160
Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial 156
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era. 156
A CONCISE 4-GENE PANEL CAN PREDICT CLINICAL OUTCOME IN URINARY BLADDER CANCER 153
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer 148
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer 147
Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study 137
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 136
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 136
Role of genetic and expression profiling in pharmacogenomics: the changing face of patient management. 133
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 132
A COMPARISON OF HAND-SEWN AND STA PLED W ILEAL RESERVOIR FOR ORTHOTO PIC BLADER REPLACEMENT 130
Significance of occult metastases to the lymph nodes in patients with prostate cancer. Results from a long term follow up study 128
Surgical treatment of a rare case of epithelioid hemangioendothelioma of the azygos vein 128
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 124
AGE AND STAGE AS PREDICTIVE FACTORS FOR A ORTHOTO PIC NEOBLADER AFTER RADICAL CYSTECTOMY: RESULTS ON 290 CASES. AGILE GROUP EXPERIENCE 123
RE-TREATMENT WITH DOCETAXEL IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC) 122
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer 118
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 118
Molecular changes of malignant mesothelioma in the testis and their impact on prognosis: Analyses of two cases 116
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 114
Adenocarcinoma della prostate stadio pN0: ruolo delle metastasi occulte 112
Reply to Erik B. Cornel's Letter to the Editor re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol 2012;61:11-25 109
Contemporary urologic minilaparoscopy: Indications, techniques, and surgical outcomes in a multi-institutional European cohort 106
an observational prospective evaluation of 3-mm transperitoneal laparoscopic pyeloplasty. Feasibility and functional results 105
A multi-center retrospective study of single-port versus multi-port video-assisted thoracoscopic lobectomy and anatomic segmentectomy 105
Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis 104
THE INTERACTION OF CELECOXIB WITH MDR TRANSPORTERS ENHANCES THE ACTIVITY OF MITOMYCIN C IN A BLADDER CANCER CELL LINE 104
“Neoplasie uroteliali della vescica.” 103
Ruolo dell’endoscopia a fluorescenza nei carcinomi uroteliali non muscolo-infiltranti e ad alto rischio della vescica. Studio osservazionale, prospettico, multicentrico 103
Biological screening of new 2-mercaptobenzothiazole derivatives for the treatment of prostate cancer 103
Biopsia prostatica, quanti prelievi?: la nostra proposta 103
DETECTION AND CLINICAL SIGNIFICANCE OF OCCULT LYMPH NODE METASTASES AND CIRCULATING CANCER CELLS IN PATIENTS WITH INVASIVE BLADDER CANCER 100
Farmacocinetica, stabilità, tollerabilità e attività della MMC somministrata tramite un nuovo dispositivo per ipertermia (UniThermia®) in pazienti “BCG failures” 100
Malignant mesothelioma of the tunica-vaginalis: one case report studied by microarray-comparative hybridization (a-CGH) 99
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up. 98
Ruolo dell’ESWL nelle urgenze della litiasi ureterale 97
Sigma-2 receptors as potential novel biomarkers during the progression of benign prostatic hypertrophy (BPH) into prostate cancer 96
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study 94
Quantitative transcriptional profilino of cell survival and cell death genes in cultured bladder cancer cells 93
Androgen deprivation therapy for prostate cancer 93
Linfoadenectomia retroperitoneale video-laparoscopica mediante accesso transperitoneale 90
The accuracy of fluorescence cystoscopy in a cohort of patients undergoing radical cystectomy 89
Athermal versus ultrasonic nerve-sparing laparoscopic radical prostatectomy: a comparison of functional and oncological outcomes 88
PCR Competitiva Standardizzata per la caratterizzazione molecolare di quattro linee cellulari vescicali 88
Xi Nerve-sparing Robotic Radical Perineal Prostatectomy: European Single-center Technique and Outcomes 88
COMBINED LIDOCAINE-PRILOCAINE CREAM AND LIDOCAINE-KETOROLAC GEL PROVIDE BETTER PAIN RELIEF THAN COMBINED LIDOCAINE-PRILOCAINE CREAM AND PERIPROSTATIC NERVE BLOCK DURING TRANSRECTAL PROSTATE BIOPSY 87
Generation of a concise gene panel for outcome prediction in urinary bladder cancer 84
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer 82
Prerectal-transperineal approach for treatment of recurrent vesico-urethral anastomotic stenosis after radical prostatectomy 81
null 81
null 81
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer 81
Correzione laparoscopica di malformazione del giunto pielo-ureterale utilizzando strumentazione da 3mm 79
Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR 79
STAT 3 activation in human bladder cancer 78
Metastasi Occulte In Linfonodi Pelvici Di Pazienti Sottoposti A Prostatectomia Radicale. Incidenza E Significato Prognostico Dopo 11 Anni Di Follow-Up Medio 78
Diagnostic accuracy of hexaminolevulinate in a cohort of patients undergoing radical cystectomy 78
Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 77
Evaluation of sigma2 receptor expression in human invasive bladder cancer 77
Human epididymal and prostate tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 76
Longer operative time and hospital stay are associated with postoperative cYstectomy complications: a modified Clavien classification system analysis 73
null 72
Molecular characterization of bladder cancer cell lines by quantitative transcript profiling using the StaRT PCR assay 70
Neoplasie uroteliali della vescica 68
The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial. 68
Entry techniques in laparoscopic radical and partial nephrectomy: A multicenter international survey of contemporary practices 68
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 67
PROCEDURE MININVASIVE PER IL TRATTAMENTO DELLA IPERTROFIA PROSTATICA BENIGNA A CONFRONTO: ENUCLEAZIONE LASER VERSUS VAPORIZZAZIONE FOTOSELETTIVA 67
Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Prostate Biopsy: Diagnostic Accuracy from a Single Center Retrospective Study 66
Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection 65
Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes 65
Intravesical electro-osmotic administration of mitomycin C 64
L’esame obiettivo 64
Prostatectomia Radicale Videolaparoscopica mediante l’uso del dispositivo Thunderbeat® 64
Neoplasie uroteliali della vescica 64
null 64
null 64
Sensitivity and reproducibility of Standardized Competitive RT PCR (StaRT PCR) for transcript quantification and its comparison with Taqman Real-time RT-PCR 63
Sexual dysfunction in patients under dialytic treatment 63
Modificazioni emoreologiche nei tumori della vescica 63
null 61
Androgen deprivation therapy and cardiovascular risk in prostate cancer 59
Severe systemic disease of the American Society of Anesthesiologists' (ASA) physical status system classification associated with delayed length of hospital stay in 1329 consecutive patients treated with radical prostatectomy for clinical prostate cancer 59
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 57
Robotic “Side Hole” Technique Placement of Ureteral Stent for Ureteral Lesion 56
Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer 54
null 54
null 52
Ectopic adrenal tissue in the kidney: A systematic review 52
null 51
Urothelial carcinoma of the prostatic urethra: Long-term follow-up study 49
Correlation between human epidermal growth factor receptor 2 (HER2) status and central nervous system (CNS) involvement in metastatic castration-resistant prostate cancer (mCRPC) 46
Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm 46
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 42
Totale 9.653
Categoria #
all - tutte 39.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022419 0 0 3 14 26 59 15 23 34 28 112 105
2022/2023898 117 87 62 82 120 119 6 115 160 9 9 12
2023/2024278 34 46 9 22 22 44 2 12 2 10 5 70
2024/20251.351 57 20 107 51 44 98 107 117 62 61 206 421
2025/20263.105 411 186 188 331 306 168 348 95 291 285 100 396
2026/2027441 128 173 140 0 0 0 0 0 0 0 0 0
Totale 9.875